ClearPoint Neuro Revenue 2010-2024 | CLPT
ClearPoint Neuro revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| ClearPoint Neuro Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $24 |
| 2022 | $21 |
| 2021 | $16 |
| 2020 | $13 |
| 2019 | $11 |
| 2018 | $7 |
| 2017 | $7 |
| 2016 | $6 |
| 2015 | $5 |
| 2014 | $4 |
| 2013 | $4 |
| 2012 | $5 |
| 2011 | $4 |
| 2010 | $3 |
| 2009 | $3 |
| ClearPoint Neuro Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $8 |
| 2024-03-31 | $8 |
| 2023-12-31 | $7 |
| 2023-09-30 | $6 |
| 2023-06-30 | $6 |
| 2023-03-31 | $5 |
| 2022-12-31 | $5 |
| 2022-09-30 | $5 |
| 2022-06-30 | $5 |
| 2022-03-31 | $5 |
| 2021-12-31 | $4 |
| 2021-09-30 | $5 |
| 2021-06-30 | $3 |
| 2021-03-31 | $4 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $2 |
| 2020-03-31 | $3 |
| 2019-12-31 | $3 |
| 2019-09-30 | $3 |
| 2019-06-30 | $3 |
| 2019-03-31 | $2 |
| 2018-12-31 | $2 |
| 2018-09-30 | $2 |
| 2018-06-30 | $2 |
| 2018-03-31 | $2 |
| 2017-12-31 | $2 |
| 2017-09-30 | $2 |
| 2017-06-30 | $2 |
| 2017-03-31 | $2 |
| 2016-12-31 | $2 |
| 2016-09-30 | $2 |
| 2016-06-30 | $1 |
| 2016-03-31 | $1 |
| 2015-12-31 | $2 |
| 2015-09-30 | $1 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $2 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.309B | $0.024B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.666B | 27.41 |
| Intuitive Surgical (ISRG) | United States | $171.263B | 96.97 |
| Alcon (ALC) | Switzerland | $47.978B | 33.77 |
| IQVIA Holdings (IQV) | United States | $41.900B | 23.74 |
| Edwards Lifesciences (EW) | United States | $39.451B | 25.29 |
| IDEXX Laboratories (IDXX) | United States | $39.315B | 47.29 |
| DexCom (DXCM) | United States | $27.294B | 38.92 |
| STERIS (STE) | Ireland | $22.782B | 26.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.950B | 0.00 |
| Waters (WAT) | United States | $20.926B | 31.20 |
| Hologic (HOLX) | United States | $18.638B | 20.26 |
| Sysmex ADR (SSMXY) | Japan | $12.525B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.147B | 13.62 |
| Teleflex (TFX) | United States | $11.270B | 17.52 |
| Globus Medical (GMED) | United States | $9.568B | 26.76 |
| Penumbra (PEN) | United States | $7.564B | 78.52 |
| Masimo (MASI) | United States | $7.385B | 39.55 |
| Glaukos (GKOS) | United States | $7.197B | 0.00 |
| TransMedics (TMDX) | United States | $4.636B | 198.53 |
| Integer Holdings (ITGR) | United States | $4.329B | 25.32 |
| PROCEPT BioRobotics (PRCT) | United States | $3.773B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.923B | 17.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.735B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.599B | 16.17 |
| Elekta AB (EKTAY) | Sweden | $2.596B | 21.15 |
| Veracyte (VCYT) | United States | $2.523B | 156.38 |
| Inari Medical (NARI) | United States | $2.443B | 0.00 |
| RxSight (RXST) | United States | $1.809B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.319B | 6.01 |
| Artivion (AORT) | United States | $1.108B | 101.69 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.066B | 19.02 |
| OPKO Health (OPK) | United States | $1.039B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.979B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.771B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.25 |
| IRadimed (IRMD) | United States | $0.631B | 34.12 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.612B | 0.00 |
| AxoGen (AXGN) | United States | $0.599B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.584B | 0.00 |
| Paragon 28 (FNA) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.469B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 10.47 |
| Treace Medical Concepts (TMCI) | United States | $0.332B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.244B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Nevro (NVRO) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.175B | 12.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.119B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 15.34 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| Envoy Medical (COCH) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.052B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Spectral AI (MDAI) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |